Association of hydroxysteroid 11-beta dehydrogenase 1 polymorphisms with chronic liver fibrosis and the occurrence of hepatocellular carcinoma in a Han Chinese population

References

• Asrani SK, Kamath PS. 2015. Model for end-stage liver disease score and MELD exceptions: 15 years later. Hepatol Int. 9:346–354.
   PubMed Web of Science ®Google Scholar
• Bertrand P, Guigliarelli B, Gayda JP. 1986. An analysis of the g values in semi-met forms of hemerythrin and in related proteins. Arch Biochem Biophys. 245:305–307.
   PubMed Web of Science ®Google Scholar
• Chedid MF, Do Nascimento FV, De Oliveira FS, De Souza BM, Kruel CRP, Gurski RR, Canani LH, Crispim D, Gerchman F. 2019. Interaction of HSD11B1 and H6PD polymorphisms in subjects with type 2 diabetes are protective factors against obesity: a cross-sectional study. Diabetol Metab Syndr. 11:78.
   PubMed Web of Science ®Google Scholar
• Devang N, Satyamoorthy K, Rai PS, Nandini M, Rao S, Phani NM, Adhikari P. 2017. Association of HSD11B1 gene polymorphisms with type 2 diabetes and metabolic syndrome in South Indian population. Diabetes Res Clin Pract. 131:142–148.
   PubMed Web of Science ®Google Scholar
• Do Nascimento FV, Piccoli V, Beer MA, Von Frankenberg AD, Crispim D, Gerchman F. 2015. Association of HSD11B1 polymorphic variants and adipose tissue gene expression with metabolic syndrome, obesity and type 2 diabetes mellitus: a systematic review. Diabetol Metab Syndr. 7:38.
   PubMed Web of Science ®Google Scholar
• Draper N, Echwald SM, Lavery GG, Walker EA, Fraser R, Davies E, Sørensen TI, Astrup A, Adamski J, Hewison M, et al. 2002. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism. J Clin Endocrinol Metab. 87:4984–4990.
   PubMed Web of Science ®Google Scholar
• Fede G, Spadaro L, Tomaselli T, Privitera G, Germani G, Tsochatzis E, Thomas M, Bouloux PM, Burroughs AK, Purrello F. 2012. Adrenocortical dysfunction in liver disease: a systematic review. Hepatology (Baltimore, Md.). 55:1282–1291.
   PubMed Web of Science ®Google Scholar
• Feigelson HS, Teras LR, Diver WR, Tang W, Patel AV, Stevens VL, Calle EE, Thun MJ, Bouzyk M. 2008. Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention study II. Breast Cancer Research: BCR. 10:R57.
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. 2018. Hepatocellular carcinoma. Lancet (London, England). 391:1301–1314.
   PubMed Web of Science ®Google Scholar
• Fox CS, Heard-Costa NL, Vasan RS, Murabito JM, D'agostino Sr. RB, Atwood LD. 2005. Genomewide linkage analysis of weight change in the Framingham Heart Study. J Clin Endocrinol Metab. 90:3197–3201.
   PubMed Web of Science ®Google Scholar
• Fujiwara K, Yasui S, Yonemitsu Y, Fukai K, Arai M, Imazeki F, Suzuki A, Suzuki H, Sadahiro T, Oda S, Yokosuka O. 2008. Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B. J Gastroenterol. 43:711–719.
   PubMed Web of Science ®Google Scholar
• Gandhi K, Adhikari P, Basu A, Achappa B. 2013. Association between a 11β-hydroxysteroid dehydrogenase type 1 gene polymorphism and metabolic syndrome in a South Indian population. Metab Syndr Relat Disord. 11:397–402.
   PubMed Web of Science ®Google Scholar
• Grolmusz VK, Acs OD, Feldman-Kovács K, Szappanos Á, Stenczer B, Fekete T, Szendei G, Reismann P, Rácz K, Patócs A. 2014. Genetic variants of the HSD11B1 gene promoter may be protective against polycystic ovary syndrome. Mol Biol Rep. 41:5961–5969.
   PubMed Web of Science ®Google Scholar
• Gronau S, Koenig Greger D, Jerg M, Riechelmann H. 2002..11Beta-hydroxysteroid dehydrogenase 1 expression in squamous cell carcinomas of the head and neck. Clin Otolaryngol Allied Sci. 27:453–457.
   PubMed Web of Science ®Google Scholar
• Harry R, Auzinger G, Wendon J. 2002. The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology (Baltimore, Md.). 36:395–402.
   PubMed Web of Science ®Google Scholar
• He B, Zhang Y, Lü MH, Cao YL, Fan YH, Deng JQ, Yang SM. 2013. Glucocorticoids can increase the survival rate of patients with severe viral hepatitis B: a meta-analysis. Eur J Gastroenterol Hepatol. 25:926–934.
   PubMed Web of Science ®Google Scholar
• Hernandez-Gea V, Friedman SL. 2011. Pathogenesis of liver fibrosis. Annu Rev Pathol. 6:425–456.
   PubMed Web of Science ®Google Scholar
• Ju R, Wu W, Tang Q, Wu D, Xia Y, Wu J, Wang X. 2015. Association analysis between the polymorphisms of HSD11B1 and H6PD and risk of polycystic ovary syndrome in Chinese population. PloS one. 10:e0140326.
   PubMedGoogle Scholar
• Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK. 2018. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the study of liver diseases. Hepatology. 68:723–750.
   PubMed Web of Science ®Google Scholar
• Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, Murray CJ, Naghavi M. 2014. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 12:145.
   PubMed Web of Science ®Google Scholar
• Morton NM, Holmes MC, Fiévet C, Staels B, Tailleux A, Mullins JJ, Seckl JR. 2001. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem. 276:41293–41300.
   PubMed Web of Science ®Google Scholar
• Paterson JM, Morton NM, Fievet C, Kenyon CJ, Holmes MC, Staels B, Seckl JR, Mullins JJ. 2004. Metabolic syndrome without obesity: hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci U S A. 101:7088–7093.
   PubMed Web of Science ®Google Scholar
• Peng Y, Qi X, Guo X. 2016. Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: A systematic review and meta-analysis of observational studies. Medicine (Baltimore). 95:e2877.
   PubMed Web of Science ®Google Scholar
• Quteineh L, Vandenberghe F, Saigi Morgui N, Delacrétaz A, Choong E, Gholam-Rezaee M, Magistretti P, Bondolfi G, Von Gunten A, Preisig M, et al. 2015. Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments. Pharmacogenet Genomics. 25:246–258.
   PubMed Web of Science ®Google Scholar
• Safaei A, Arefi Oskouie A, Mohebbi SR, Rezaei-Tavirani M, Mahboubi M, Peyvandi M, Okhovatian F, Zamanian-Azodi M. 2016. Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases. Gastroenterol Hepatol Bed Bench. 9:158–173.
   PubMedGoogle Scholar
• Seckl JR, Walker BR. 2001. Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action. Endocrinology. 142:1371–1376.
   PubMed Web of Science ®Google Scholar
• Stasi C, Silvestri C, Voller F, Cipriani F. 2015. Epidemiology of liver cirrhosis. J Clin Exp Hepatol. 5:272.
   PubMedGoogle Scholar
• Ter-Minassian M, Asomaning K, Zhao Y, Chen F, Su L, Carmella SG, Lin X, Hecht SS, Christiani DC. 2012. Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL). Int J Cancer. 130:1338–1346.
   PubMed Web of Science ®Google Scholar
• Terrault NA, Lok ASF, Mcmahon BJ, Chang KM, Hwang JP, Jonas MM, Brown Jr. RS, Bzowej NH, Wong JB. 2018. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 67:1560–1599.
   PubMed Web of Science ®Google Scholar
• Tsai MH, Peng YS, Chen YC, Liu NJ, Ho YP, Fang JT, Lien JM, Yang C, Chen PC, Wu CS. 2006. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology (Baltimore, Md.). 43:673–681.
   PubMed Web of Science ®Google Scholar
• Tsochatzis EA, Bosch J, Burroughs AK. 2014. Liver cirrhosis. Lancet (London, England). 383:1749–1761.
   PubMed Web of Science ®Google Scholar
• Wang J, Gao Y, Wang L, Liu X, Li J, Wang Z, Zhou J, Wang K. 2013. A variant (rs932335) in the HSD11B1 gene is associated with colorectal cancer in a Chinese population. Eur J Cancer Prev. 22:523–528.
   PubMed Web of Science ®Google Scholar
• Wen D, Zou W, Wen X, Yang Y, Chen Y, He Y, Wang G, Shan B. 2018. Urban-rural disparity in colorectal cancer incidence and increasing trend in relation to socioeconomic development and urbanization in China. J Int Med Res. 46:4181–4196.
   PubMed Web of Science ®Google Scholar
• Yang CH, Wu TS, Chiu CT. 2007. Chronic hepatitis B reactivation: a word of caution regarding the use of systemic glucocorticosteroid therapy. Br J Dermatol. 157:587–590.
   PubMed Web of Science ®Google Scholar
• Zhang B, Wang J, Xu W, Wang L, Ni W. 2010. Fatal reactivation of occult hepatitis B virus infection after rituximab and chemotherapy in lymphoma: necessity of antiviral prophylaxis. Onkologie. 33:537–539.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhang JY, Yu HW, He YL, Zhao JJ, Li J, Zhu YK, Yao QW, Wang JH, Liu HX, et al. 2012. Improved survival ratios correlate with myeloid dendritic cell restoration in acute-on-chronic liver failure patients receiving methylprednisolone therapy. Cell Mol Immunol. 9:417–422.
   PubMed Web of Science ®Google Scholar
• Zhao RH, Shi Y, Zhao H, Wu W, Sheng JF. 2018. Acute-on-chronic liver failure in chronic hepatitis B: an update. Expert Rev Gastroenterol Hepatol. 12:341–350.
   PubMed Web of Science ®Google Scholar